Sweeney CT, Kozlowski LT, Parsa P. 1999. Effect of filter vent blocking on carbon monoxide exposure from selected lower tar cigarette brands. Pharmacology Biochemistry and Behavior 63(1):167–173.


Tauras J, Chaloupka F. 1999. Price, clean indoor air, and cigarette smoking: evidence from the longitudinal data for young abults (NBER Working Paper W 6937. [Online]. Available: http://www.nberws.nber.org/papers/W6937 [accessed 2001].

Taylor WA, Gold MS. 1990. Pharmcologic approaches to the treatment of cocaine dependence. Western Journal of Medicine 152(Addiction Medicine):573–577.

Thun MJ, Day-Lally CA, Calle EE, Flanders WD, Heath CW. 1995. Excess mortality among cigarette smokers: changes in a 20-year interval. Am J Public Health 85(9):1223–1230.

Tonnesen P, Norregaard J, Mikkelsen K, Jorgensen S, Nilsson F. 1993. A double-blind trial of a nicotine inhaler for smoking cessation . JAMA 269(10):1268–1271.

Transdermal Nicotine Study Group. 1991. Transdermal nicotine for smoking cessation. Six-month results from two multicenter controlled clinical trials. JAMA 266(22):3133–3138.

Tyndale R, Rao Y, Bodin L, et al. 2000. CYP2A6 gene defects and duplications alter objective indices of smoking. Clincal Pharmacology and Therapeutics 67(2):113.


U.S. DHHS (U.S. Department of Health and Human Services). 1986. The Health Consequences of Involuntary Smoking: A Report of the Surgeon General. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention.

U.S. DHHS (U.S. Department of Health and Human Services). 1994. Preventing Tobacco Use Among Young People: A Report of the Surgeon General. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention.

U.S. DHHS (U.S. Department of Health and Human Services). 1995. Analysis regarding the Food and Drug Administration’s jurisdiction over nicotine-containing cigarettes and smokeless tobacco products. Federal Register 60(155):41453.

U.S. DHHS (U.S. Department of Health and Human Services). 1998. Tobacco Use Among U.S. Racial/Ethnic Minority Groups. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention.

U.S. DHHS (U.S. Department of Health and Human Services). 2000. Reducing Tobacco Use: A Report of the Surgeon General. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention.


Wakefield MA, Wilson D, Owen N, Esterman A, Roberts L. 1992. Workplace smoking restrictions, occupational status, and reduced cigarette consumption. J Occup Med 34(7):693–697.

Warner KE, Slade J, Sweanor DT. 1997. The emerging market for long-term nicotine maintenance. JAMA 278(13):1087–1092.

Was Safer Cigarette Research Snuffed? 1994. Science 264

(5160):766–767.

Waters AJ, Jarvis MJ, Sutton SR. 1998. Nicotine Withdrawal and accident rates. Nature 394(137).

Watkins SS, Koob GF, Markou A. 2000. Neural mechanisms underlying nicotine addiction: acute positive reinforcement and withdrawal. Nicotine Tob Res 2(1):19–37.

West R, Hajek P, McNeill A. 1991. Effect of buspirone on cigarette withdrawal symptoms and short-term abstinence rates in a smokers clinic. Psychopharmacology (Berl) 104(1):91–96.

Westman E, Tomlin K, Rose J. 2000. Combining the nicotine inhaler and nicotine patch for smoking cessation. American Journal of Health Behavior 24(2):114–119.

Women who smoke menthol cigarettes have greater nicotine exposure. 1999. Oncology (Huntingt) 13(7):915.

Wong GY, Wolter TD, Croghan GA, Croghan IT, Offord KP, Hurt RD. 1999. A randomized trial of naltrexone for smoking cessation. Addiction 94(8):1227–1237.

Working Group for the Study of Transdermal Nicotine in Patients with Coronary Artery Disease. 1994. Nicotine replacement therapy for patients with coronary artery disease. Arch Intern Med 154(9):989–995.



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement